|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001554,
umls-concept:C0005821,
umls-concept:C0030705,
umls-concept:C0035173,
umls-concept:C0039082,
umls-concept:C0041199,
umls-concept:C0080103,
umls-concept:C0086045,
umls-concept:C0247025,
umls-concept:C0475224,
umls-concept:C0814195,
umls-concept:C0948089,
umls-concept:C1273870,
umls-concept:C1514761,
umls-concept:C1514983,
umls-concept:C2348767,
umls-concept:C2603343
|
|
pubmed:issue |
9192
|
|
pubmed:dateCreated |
1999-12-10
|
|
pubmed:abstractText |
A major challenge for physicians is to identify patients with acute coronary syndromes who may benefit from treatment with glycoprotein-IIb/IIIa-receptor antagonists. We investigated whether troponin concentrations can be used to stratify patients for benefit from treatment with tirofiban.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0140-6736
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
20
|
|
pubmed:volume |
354
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1757-62
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10577636-Aged,
pubmed-meshheading:10577636-Biological Markers,
pubmed-meshheading:10577636-Coronary Disease,
pubmed-meshheading:10577636-Creatine Kinase,
pubmed-meshheading:10577636-Female,
pubmed-meshheading:10577636-Fibrinolytic Agents,
pubmed-meshheading:10577636-Heparin,
pubmed-meshheading:10577636-Humans,
pubmed-meshheading:10577636-Infusions, Intravenous,
pubmed-meshheading:10577636-Isoenzymes,
pubmed-meshheading:10577636-Male,
pubmed-meshheading:10577636-Middle Aged,
pubmed-meshheading:10577636-Myocardial Infarction,
pubmed-meshheading:10577636-Platelet Aggregation Inhibitors,
pubmed-meshheading:10577636-Risk Factors,
pubmed-meshheading:10577636-Troponin I,
pubmed-meshheading:10577636-Troponin T,
pubmed-meshheading:10577636-Tyrosine
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. PRISM Study Investigators. Platelet Receptor Inhibition in Ischemic Syndrome Management.
|
|
pubmed:affiliation |
Department of Cardiovascular Medicine, Stanford University Medical School, CA, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
